Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Gemcitabine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gemcitabine 1.5g powder for solution for infusion vials
0801030X0AAACAC
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g powder for solution for infusion vials
0801030X0AAAAAA
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/10ml solution for infusion vials
0801030X0AAAIAI
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/25ml solution for infusion vials
0801030X0AAALAL
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/26.3ml solution for infusion vials
0801030X0AAAFAF
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 200mg powder for solution for infusion vials
0801030X0AAABAB
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 200mg/2ml solution for infusion vials
0801030X0AAAHAH
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 200mg/5.26ml solution for infusion vials
0801030X0AAANAN
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 200mg/5.3ml solution for infusion vials
0801030X0AAAEAE
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 200mg/5ml solution for infusion vials
0801030X0AAAKAK
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 2g powder for solution for infusion vials
0801030X0AAADAD
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 2g/20ml solution for infusion vials
0801030X0AAAJAJ
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 2g/50ml solution for infusion vials
0801030X0AAAMAM
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 2g/52.6ml solution for infusion vials
0801030X0AAAGAG
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemzar 1g powder for solution for infusion vials
0801030X0BBAAAA
|
Gemzar | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemzar 200mg powder for solution for infusion vials
0801030X0BBABAB
|
Gemzar | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.